Home > Boards > US OTC > Medical - Equipment > SiNtx Technologies, Inc. (AMDDW)

This is repeating, but with more links, hopefully

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
KOmani Member Profile
 
Followed By 27
Posts 1,863
Boards Moderated 0
Alias Born 09/22/15
160x600 placeholder
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 6/3/2020 10:59:47 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/13/2020 5:02:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/30/2020 4:32:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/30/2020 4:31:42 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/26/2020 6:07:49 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/23/2020 9:00:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/4/2020 7:01:02 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/2/2020 7:46:36 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/10/2020 3:16:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/7/2020 5:22:03 PM
Registration of Additional Securities (up to 20%) (s-1mef) Edgar (US Regulatory) - 2/3/2020 4:40:28 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/30/2020 8:26:36 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 1/29/2020 8:02:31 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 1/21/2020 6:00:54 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 1/17/2020 5:02:46 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 1/17/2020 6:04:03 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 1/15/2020 2:03:59 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 1/10/2020 5:22:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/27/2019 4:30:50 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 12/27/2019 4:12:11 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 12/9/2019 4:07:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/18/2019 7:31:09 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/13/2019 4:01:00 PM
KOmani   Sunday, 06/28/20 11:49:38 AM
Re: Luckypennyman post# 14
Post # of 21 
This is repeating, but with more links, hopefully you can see?

Here is the recent Prospectus on iHub (from when they issued shares recently):

https://ih.advfn.com/stock-market/NASDAQ/sintx-technologies-SINT/stock-news/82723577/prospectus-filed-pursuant-to-rule-424b5-424b5

Quote:
May 2018 Public Offering Warrants



On May 14, 2018, we issued 11,370,000 common stock warrants (the “May 2018 Warrants”) in a public offering. The material terms and provisions of the May 2018 Warrants are summarized below. This summary of the May 2018 Warrants is not complete. For the complete terms of the May 2018 Warrants, you should refer to the form of May 2018 Warrant filed as an exhibit to the registration statement of which this prospectus forms a part.



Pursuant to a warrant agency agreement between us and American Stock Transfer & Trust Company, LLC, as warrant agent, the May 2018 Warrants were issued in book-entry form and are represented only by one or more global warrants deposited with the warrant agent, as custodian on behalf of The Depository Trust Company, or DTC, and registered in the name of Cede & Co., a nominee of DTC, or as otherwise directed by DTC.



Exercisability, Exercise Price and Term. The May 2018 Warrants entitle the holder to purchase shares of our common stock at an exercise price equal to $0.48 per share. The May 2018 Warrants were exercisable immediately and expire on the five-year anniversary of the issuance date. The holder of a May 2018 Warrant will not be deemed a holder of our underlying common stock until the May 2018 Warrant is exercised, except as set forth in the May 2018 Warrants.



The exercise price and the number of shares issuable upon exercise of the May 2018 Warrants is subject to appropriate adjustment, similar to that described with respect to the Series B Preferred Stock above, in the event of recapitalization events, stock dividends, stock splits, stock combinations, reclassifications, reorganizations or similar events affecting our common stock. Subject to certain exclusions contained in the May 2018 Warrant, the exercise price is also subject to adjustment in the event that we sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any common stock or common stock equivalents (as defined in the May 2018 Warrants), at an effective price per share less than the exercise price then in effect (including in the event we issued Series B Preferred Stock at a conversion price lower than the initial conversion price of the Series B Preferred Stock). In addition, May 2018 Warrant holders may be eligible to elect an alternative price in the event we issue certain variable price securities. The May 2018 Warrant holders must pay the exercise price in cash upon exercise of the May 2018 Warrants, unless such May 2018 Warrant holders are utilizing the cashless exercise provision of the May 2018 Warrants, which is only available in certain circumstances such as if the underlying shares are not registered with the SEC pursuant to an effective registration statement.



Fundamental Transactions. In addition, in the event we consummate a merger or consolidation with or into another person or other reorganization event in which our common shares are converted or exchanged for securities, cash or other property, or we sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially all of our assets or we or another person acquires 50% or more of our outstanding shares of common stock, referred to as a fundamental transaction, then following such event, the holders of the May 2018 Warrants will be entitled to receive upon exercise of the May 2018 Warrants the same kind and amount of securities, cash or property which the holders would have received had they exercised the May 2018 Warrants immediately prior to such fundamental transaction. Any successor to us or surviving entity is required to assume the obligations under the warrants. Notwithstanding the foregoing, in the event of a fundamental transaction, the holders will have the option, which may be exercised within 30 days after the consummation of the fundamental transaction, to require the company or the successor entity purchase the Warrant from the holder by paying to the holder an amount of cash equal to the Black Scholes value of the remaining unexercised portion of the warrant on the date of the consummation of the fundamental transaction. However, if the fundamental transaction is not within the company’s control, including not approved by the company’s Board of Directors, the holder will only be entitled to receive from the company or any successor entity, as of the date of consummation of such fundamental transaction, the same type or form of consideration (and in the same proportion), at the Black Scholes value of the unexercised portion of the May 2018 Warrant, that is being offered and paid to the holders of common stock of the company in connection with the fundamental transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of common stock are given the choice to receive from among alternative forms of consideration in connection with the fundamental transaction.


12




Upon the holder’s exercise of a May 2018 Warrant, we will issue the shares of common stock issuable upon exercise of the May 2018 Warrant within two trading days following our receipt of a notice of exercise, provided that payment of the exercise price has been made (unless exercised via the “cashless” exercise provision).



Prior to the exercise of any May 2018 Warrants to purchase common stock, holders of the May 2018 Warrants will not have any of the rights of holders of the common stock purchasable upon exercise, including the right to vote, except as set forth therein.



May 2018 Warrant holders may exercise the May 2018 Warrants only if the issuance of the shares of common stock upon exercise of the May 2018 Warrants is covered by an effective registration statement, or an exemption from registration is available under the Securities Act and the securities laws of the state in which the holder resides. The May 2018 Warrant holders must pay the exercise price in cash upon exercise of the May 2018 Warrants unless there is not an effective registration statement or, if required, there is not an effective state law registration or exemption covering the issuance of the shares underlying the May 2018 Warrants (in which case, the May 2018 Warrants may only be exercised via a “cashless” exercise provision).



Beneficial Ownership Limitation. The May 2018 Warrant provides that we may not effect any exercise of the May 2018 Warrants, with certain exceptions, to the extent that, after giving effect to an attempted exercise, the holder (together with such holder’s affiliates, and any persons acting as a group together with such holder or any of such holder’s affiliates) would beneficially own a number of shares of common stock in excess of 4.99% (or, at the election of the holder, 9.99%) of the shares of our common stock then outstanding after giving effect to such exercise, referred to as the May 2018 Warrant Beneficial Ownership Limitation; provided, however, that upon notice to the Company, the holder may increase or decrease the May 2018 Warrant Beneficial Ownership Limitation, provided that in no event may the May 2018 Warrant Beneficial Ownership Limitation exceed 9.99% and any increase in the May 2018 Warrant Beneficial Ownership Limitation will not be effective until 61 days following notice of such increase from the holder to us.



Cashless Exercise. If a May 2018 Warrant is exercised via the “cashless” exercise provision, the holder will receive the number of shares equal to the quotient obtained by dividing (i) the difference between the VWAP (as determined pursuant to the terms of the May 2018 Warrants) and the exercise price of the May 2018 Warrant multiplied by the number of shares issuable under the May 2018 Warrant if such exercise were by means of a cash exercise by (ii) the VWAP (as determined pursuant to the terms of the May 2018 Warrants).



Jurisdiction and Waiver of Trial by Jury. Other than with respect to suits, actions or proceedings arising under the federal securities laws, the May 2018 Warrant provides for investors to consent to exclusive jurisdiction to courts located in New York, New York and provides for a waiver of the right to a trial by jury. It also provides that disputes are governed by New York law.



As I mentioned, for these warrants, it is important to note that the exercise price is continuously reduced to the lowest price that the company sells shares to the public or at which preferred shares can convert to.

After further review ....

I believe the $0.48 is presplit .... so we need to find the lowest price offered since the split.

The lowest price offered since the split seems to be $1.4814

As mentioned here:

https://www.sintx.com/news-media/press-releases/detail/144/sintx-technologies-announces-expiration-of-oversubscribed

At this point, I am unclear of whether 1 warrant or 30 warrants are needed to purchase 1 share.

If it is 1 warrant = 1 share, then the implied price is $0.5186 at $2.00

On the other hand, if it is now 30 warrants = 1 share, this implies a value of $0.017286

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist